About Us

The future of PPE

A safer, smarter solution to the threats posed by deadly infectious viruses

Hero Image

The challenge we face globally

Current PPE is not keeping us safe enough

SARS-CoV-2 is transmitted through large respiratory droplets generated by coughing, sneezing or even speaking, which can also survive on surfaces.

PPE plays a crucial role in interrupting the transmission of SARS-CoV-2, but research has found that a high level of viral load and the process of putting PPE on and taking it off presents a substantially increased risk of transmission.

The disposal of contaminated PPE also presents a further transmission risk, as does concern regarding the disposal of single-use PPE from a waste management perspective.

Frontline Workers

Lack of appropriate PPE

  • Contact with used PPE increases the risk of transmission via fomites
  • Rules around single-use PPE disposal are resulting in enormous quantities of used PPE going into landfill and our oceans
  • Without access to adequate PPE, healthcare workers are more likely to become ill
    • Ill healthcare workers create a supply shortage during high demand, and can contribute to further viral transmission
    • Remaining available health workers are stretched beyond capacity and quality of care often reduces
  • PPE shortage becomes a system-wide public health problem, rather than solely a worker’s rights or occupational health issue
  • PPE for health workers is a key component of infection prevention and control; ensuring that healthcare workers are protected means more chance of preventing infection and therefore less chance of community transmission
View our Products

The Statistics


As of May 2020, 87% of nurses in the US reported having to reuse disposable single-use N95 and respirator masks. 27% reported that they had been exposed to patients with confirmed COVID-19, without wearing appropriate PPE.


As of August 15th, 2020, 300,000 healthcare workers had been infected with COVID-19. In addition to the high number of infections, over 2,500 healthcare workers died from the virus as of that time.


In March 2020, one-third of hospitals had almost no face masks and 13% reported to have run out of plastic face shields.

The virus needs to be neutralised, not just blocked, to further reduce the risk of transmission through the air or by contact.

ViraCoat's COVID-Eliminating PPE will:

Neutralise the threat upon contact

Vaccines alone are not completely effective against becoming seriously ill from COVID-19, and most do not effectively reduce transmissibility. Current vaccines are also likely to become less effective as the virus continues to mutate into new variants.

Having a COVID-killing coating that starts working immediately upon contact with the virus acts as an invisible ‘circuit-breaker’ in the transmission of COVID-19 via fomites and airborne droplets.

Health authorities (including the WHO) recommend that a multifaceted approach of prevention and protection is the only route to controlling COVID-19 in a sustainable manner long-term.


ViraCoat has developed a patented Virucidal, Antiviral & Antimicrobial Coating which has been scientifically demonstrated to have profound antiviral properties against SARS-CoV-2 (including new variants), Influenza (PR8 strain), and Bacteria (E. coli).

ViraCoat’s patented Coating has been incorporated into the ViraCoat COVID-19 eliminating Antiviral FFP2 Mask at a manufacturing level, to inactivate the virus and help reduce the spread of SARS-CoV-2, other viruses and bacteria within 5 minutes of contact.*

The mask is manufactured by ViraCoat in state-of-the-art Module D PPE manufacturing facilities, using our proprietary Virucidal, Antiviral & Antimicrobial Coating and other exclusively-sourced components to the highest possible standards.

* Based on current lab testing results to date.

View our Products

Contact Us

Expression of Interest

Contact Form Image

    I am making a general enquiry.I would like to become a distributor.